{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:27:57Z","timestamp":1781663277487,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570364"],"award-info":[{"award-number":["81570364"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873468"],"award-info":[{"award-number":["81873468"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007194","name":"Wenzhou Science and Technology Bureau","doi-asserted-by":"publisher","award":["Y20150032"],"award-info":[{"award-number":["Y20150032"]}],"id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007194","name":"Wenzhou Science and Technology Bureau","doi-asserted-by":"publisher","award":["Y20170021"],"award-info":[{"award-number":["Y20170021"]}],"id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation for the Program of the Provincial Health Department of Zhejiang Province of China","award":["2019RC051"],"award-info":[{"award-number":["2019RC051"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.lfs.2019.01.017","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T11:10:53Z","timestamp":1547550653000},"page":"177-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Spironolactone inhibits endothelial-mesenchymal transition via the adenosine A2A receptor to reduce cardiorenal fibrosis in rats"],"prefix":"10.1016","volume":"224","author":[{"given":"Xingxing","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiancheng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2019.01.017_bb0005","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/eurheartj\/ehp507","article-title":"Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative","volume":"31","author":"Ronco","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.lfs.2019.01.017_bb0010","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.amjcard.2014.09.055","article-title":"Effect of renal function on prognosis in chronic heart failure","volume":"115","author":"L\u00f6ffler","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.lfs.2019.01.017_bb0015","first-page":"R267","article-title":"Maternal and fetal adaptations during pregnancy: lessons in regulatory and integrative physiology","volume":"301","author":"Granger","year":"2002","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"key":"10.1016\/j.lfs.2019.01.017_bb0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","article-title":"Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised placebo-controlled trial","volume":"381","author":"Teerlink","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2019.01.017_bb0025","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jacc.2012.11.005","article-title":"Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the relaxin in acute heart failure (RELAX-AHF) development program: correlation with outcomes","volume":"61","author":"Metra","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.lfs.2019.01.017_bb0030","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/CIRCULATIONAHA.117.028814","article-title":"Cardiorenal syndrome revisited","volume":"138","author":"Zannad","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2019.01.017_bb0035","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.ijcard.2012.12.065","article-title":"Subtotal nephrectomy accelerates pathological cardiac remodeling post-myocardial infarction: implications for cardiorenal syndrome","volume":"168","author":"Liu","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.lfs.2019.01.017_bb0040","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1161\/01.RES.74.4.727","article-title":"Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat","volume":"74","author":"Crawford","year":"1994","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2019.01.017_bb0045","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1159\/000430310","article-title":"Early spironolactone treatment attenuates heart failure development by improving myocardial function and reducing fibrosis in spontaneously hypertensive rats","volume":"36","author":"Cezar","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2019.01.017_bb0050","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ejphar.2008.06.019","article-title":"Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats","volume":"589","author":"Taira","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2019.01.017_bb0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jchf.2014.08.002","article-title":"The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries","volume":"3","author":"Calvier","year":"2015","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.lfs.2019.01.017_bb0060","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1159\/000464125","article-title":"Anti-fibrosis effect of relaxin and spironolactone combined on isoprenaline-induced myocardial fibrosis in rats via inhibition of endothelial-mesenchymal transition","volume":"41","author":"Cai","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2019.01.017_bb0065","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1016\/j.ajpath.2011.07.042","article-title":"Inflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosis","volume":"179","author":"Rieder","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2019.01.017_bb0070","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s10157-013-0781-0","article-title":"Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease","volume":"17","author":"He","year":"2013","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.lfs.2019.01.017_bb0075","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm1613","article-title":"Endothelial-to-mesenchymal transition contributes to cardiac fibrosis","volume":"13","author":"Zeisberg","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2019.01.017_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/jcm5040045","article-title":"Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of human fibrotic diseases","volume":"5","author":"Piera-Velazquez","year":"2016","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.lfs.2019.01.017_bb0085","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/eurheartj\/ehp555","article-title":"Cardioprotective effects of mineralocorticoid receptor antagonists at reperfusion","volume":"31","author":"Schmidt","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.lfs.2019.01.017_bb0090","first-page":"1471","article-title":"Thrombospondins in cancer","volume":"64","author":"Kazerounian","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.lfs.2019.01.017_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039919","article-title":"Cardioprotection of controlled and cardiac-specific over-expression of a2A-adenosine receptor in the pressure overload","volume":"7","author":"Hamad","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2019.01.017_bb0100","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/ki.2011.101","article-title":"Adenosine A2Areceptor activation prevents progressive kidney fibrosis in a model of immune-associated chronic inflammation","volume":"80","author":"Garcia","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2019.01.017_bb0105","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1096\/fj.15-280388","article-title":"Adenosine A2A receptor plays an important role in radiation-induced dermal injury","volume":"30","author":"Perez-Aso","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2019.01.017_bb0110","article-title":"Adenosine A2A receptor: a target for regulating renal interstitial fibrosis in obstructive nephropathy","volume":"8","author":"Xiao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2019.01.017_bb0115","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.bbrc.2017.03.120","article-title":"Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma","volume":"486","author":"Cheng","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2019.01.017_bb0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrneph.2012.279","article-title":"Cardiorenal syndrome: pathophysiology and potential targets for clinical management","volume":"9","author":"Hatamizadeh","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.lfs.2019.01.017_bb0125","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMra1300575","article-title":"Fibrosis - a common pathway to organ injury and failure","volume":"372","author":"Rockey","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2019.01.017_bb0130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/clc.20324","article-title":"A comparison of the aldosterone-blocking agents eplerenone and spironolactone","volume":"31","author":"Struthers","year":"2008","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.lfs.2019.01.017_bb0135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijcard.2015.07.038","article-title":"Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF)","volume":"200","author":"Capuano","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.lfs.2019.01.017_bb0140","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-016-0294-1","article-title":"Baicalin attenuates bleomycin-induced pulmonary fibrosis via adenosine A2a receptor related TGF-\u03b21-induced ERK1\/2 signaling pathway","volume":"16","author":"Huang","year":"2016","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.lfs.2019.01.017_bb0145","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1124\/jpet.109.157651","article-title":"Adenosine suppresses lipopolysaccharide-induced tumor necrosis factor-alpha production by murine macrophages through a protein kinase A- and exchange protein activated by cAMP-independent signaling pathway","volume":"331","author":"Kreckler","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2019.01.017_bb0150","doi-asserted-by":"crossref","first-page":"25833","DOI":"10.1074\/jbc.274.36.25833","article-title":"Activation of mitogen-activated protein kinase by the A(2A)-adenosine receptor via a rap1-dependent and via a p21(ras)-dependent pathway","volume":"274","author":"Seidel","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2019.01.017_bb0155","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11302-017-9571-6","article-title":"Modulation of the TGF-\u03b21-induced epithelial to mesenchymal transition (EMT) mediated by P1 and P2 purine receptors in MDCK cells","volume":"13","author":"Zuccarini","year":"2017","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.lfs.2019.01.017_bb0160","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s11302-013-9368-1","article-title":"Adenosine A2A receptor (A2AR) is a fine-tune regulator of the collagen1: collagen3 balance","volume":"9","author":"Perez-Aso","year":"2013","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.lfs.2019.01.017_bb0165","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/01.CIR.95.6.1363","article-title":"Plasma adenosine levels increase in patients with chronic heart failure","volume":"95","author":"Funaya","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2019.01.017_bb0170","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1291\/hypres.30.781","article-title":"Impact of adenosine receptor signaling and metabolism on pathophysiology in patients with chronic heart failure","volume":"30","author":"Asakura","year":"2007","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.lfs.2019.01.017_bb0175","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1053\/ajkd.2001.26888","article-title":"Systemic adenosine given after ischemia protects renal function via A2aadenosine receptor activation","volume":"38","author":"Lee","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.lfs.2019.01.017_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111248","article-title":"The effect of eplerenone on adenosine formation in humans in vivo: a double-blinded randomised controlled study","volume":"9","author":"Van Den Berg","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2019.01.017_bb0185","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/sj.bjp.0706812","article-title":"Adenosine A2A receptors play a role in the pathogenesis of hepatic cirrhosis","volume":"148","author":"Chan","year":"2006","journal-title":"Br. J. Pharmacol."}],"updated-by":[{"DOI":"10.1016\/j.lfs.2022.120430","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000}}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432051930027X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432051930027X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:20:52Z","timestamp":1758399652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432051930027X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":37,"alternative-id":["S002432051930027X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2019.01.017","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.lfs.2022.120430","asserted-by":"object"}]},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spironolactone inhibits endothelial-mesenchymal transition via the adenosine A2A receptor to reduce cardiorenal fibrosis in rats","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2019.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}